245 related articles for article (PubMed ID: 33139801)
1. Serum lipid profiles and risk of colorectal cancer: a prospective cohort study in the UK Biobank.
Fang Z; He M; Song M
Br J Cancer; 2021 Feb; 124(3):663-670. PubMed ID: 33139801
[TBL] [Abstract][Full Text] [Related]
2. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.
His M; Zelek L; Deschasaux M; Pouchieu C; Kesse-Guyot E; Hercberg S; Galan P; Latino-Martel P; Blacher J; Touvier M
Eur J Epidemiol; 2014 Feb; 29(2):119-32. PubMed ID: 24519551
[TBL] [Abstract][Full Text] [Related]
3. Lipid biomarkers and long-term risk of cancer in the Women's Health Study.
Chandler PD; Song Y; Lin J; Zhang S; Sesso HD; Mora S; Giovannucci EL; Rexrode KE; Moorthy MV; Li C; Ridker PM; Lee IM; Manson JE; Buring JE; Wang L
Am J Clin Nutr; 2016 Jun; 103(6):1397-407. PubMed ID: 27099252
[TBL] [Abstract][Full Text] [Related]
4. The association of serum lipids with colorectal adenomas.
Yang MH; Rampal S; Sung J; Choi YH; Son HJ; Lee JH; Kim YH; Chang DK; Rhee PL; Kim JJ; Rhee JC; Chun HK; Guallar E; Cho J
Am J Gastroenterol; 2013 May; 108(5):833-41. PubMed ID: 23545715
[TBL] [Abstract][Full Text] [Related]
5. Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women.
Dugani SB; Moorthy MV; Li C; Demler OV; Alsheikh-Ali AA; Ridker PM; Glynn RJ; Mora S
JAMA Cardiol; 2021 Apr; 6(4):437-447. PubMed ID: 33471027
[TBL] [Abstract][Full Text] [Related]
6. Serum Lipid Profiles and Cholesterol-Lowering Medication Use in Relation to Subsequent Risk of Colorectal Cancer in the UK Biobank Cohort.
Yuan F; Wen W; Jia G; Long J; Shu XO; Zheng W
Cancer Epidemiol Biomarkers Prev; 2023 Apr; 32(4):524-530. PubMed ID: 36780218
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
[TBL] [Abstract][Full Text] [Related]
8. Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease.
Ford ES; Cooper RS; Simmons B; Castaner A
J Clin Epidemiol; 1990; 43(5):425-32. PubMed ID: 2109048
[TBL] [Abstract][Full Text] [Related]
9. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
[TBL] [Abstract][Full Text] [Related]
10. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
11. Apolipoproteins, lipids and risk of cancer.
Borgquist S; Butt T; Almgren P; Shiffman D; Stocks T; Orho-Melander M; Manjer J; Melander O
Int J Cancer; 2016 Jun; 138(11):2648-56. PubMed ID: 26804063
[TBL] [Abstract][Full Text] [Related]
12. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
[TBL] [Abstract][Full Text] [Related]
13. Visceral Adiposity Index is a predictor of incident colorectal cancer: a population-based longitudinal study.
Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
BMJ Open Gastroenterol; 2020 Jun; 7(1):. PubMed ID: 32595114
[TBL] [Abstract][Full Text] [Related]
14. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition.
van Duijnhoven FJ; Bueno-De-Mesquita HB; Calligaro M; Jenab M; Pischon T; Jansen EH; Frohlich J; Ayyobi A; Overvad K; Toft-Petersen AP; Tjønneland A; Hansen L; Boutron-Ruault MC; Clavel-Chapelon F; Cottet V; Palli D; Tagliabue G; Panico S; Tumino R; Vineis P; Kaaks R; Teucher B; Boeing H; Drogan D; Trichopoulou A; Lagiou P; Dilis V; Peeters PH; Siersema PD; Rodríguez L; González CA; Molina-Montes E; Dorronsoro M; Tormo MJ; Barricarte A; Palmqvist R; Hallmans G; Khaw KT; Tsilidis KK; Crowe FL; Chajes V; Fedirko V; Rinaldi S; Norat T; Riboli E
Gut; 2011 Aug; 60(8):1094-102. PubMed ID: 21383385
[TBL] [Abstract][Full Text] [Related]
15. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
[TBL] [Abstract][Full Text] [Related]
16. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
[TBL] [Abstract][Full Text] [Related]
18. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
[TBL] [Abstract][Full Text] [Related]
19. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
[TBL] [Abstract][Full Text] [Related]
20. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
Straczek C; Tafflet M; Barberger-Gateau P; Bertrand M; Dupuy AM; Ducimetière P; Empana JP
Atherosclerosis; 2011 Feb; 214(2):426-31. PubMed ID: 21129746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
